Frontiers in Pharmacology · 2021 · 23 citations · 24 references
MedicineBiochemistryCell BiologyBone MetabolismCell SignalingCellular MetabolismBone FormationBone PhysiologyBone TissueOsteoblast BiologyOsteoblast FunctionOsteoporosisBone BiologyDegenerative Cell ChangesOsteogenic MarkersRankl Opg SignalingTrabecular ArchitectureTrabecular Bone ArchitectureTrabecular Bone LossTrabecular Bone Microarchitecture
Objective: The overall objective of this study was to investigate the effects of catalpol on bone remodeling of diabetic osteoporosis by regulating osteoblast differentiation and migration. Method: Using a murine model of diabetic osteoporosis, to detect the protective effects of catalpol on bone loss, architectural deterioration of trabecular bone and bone metabolism biomarkers were tested. A model of MC3T3-E1 cells was established by treatment with high glucose; the regulatory role of catalpol in the differentiation and migration was tested by Western blot, ALP staining, and Alizarin Red staining. Results: Catalpol treatment markedly ameliorated trabecular bone deterioration by reducing degenerative changes of the trabecular structure by improving the bone formation marker levels of ALP, osteopontin, type I collagen, and osteocalcin, as well as the level of OPG/RANKL. Catalpol enhanced cell motility and scattering following gap formation of MC3T3-E1 cells. Conclusion: The results indicated that catalpol exhibits a protective effect against diabetic osteoporosis by regulating the differentiation and migration of osteoblast.
24
Wan Gong, Nai-Dan Zhang, Gang Cheng et al. · International Journal of Molecular Sciences · 2019 · 131 citations · Full text
Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells
Fei Li, Ya‐Nan Yang, Panpan Zhu et al. · Fitoterapia · 2012 · 78 citations
Medicine, Surgery, Bone Metabolism +13